- Home
- FMY vs FBIO Comparison
FMY vs FBIO Comparison
Compare FMY & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMY
- FBIO
- Stock Information
- Founded
- FMY 2005
- FBIO 2006
- Country
- FMY United States
- FBIO United States
- Employees
- FMY N/A
- FBIO N/A
- Industry
- FMY Finance/Investors Services
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- FMY Finance
- FBIO Health Care
- Exchange
- FMY Nasdaq
- FBIO Nasdaq
- Market Cap
- FMY 49.6M
- FBIO 49.1M
- IPO Year
- FMY N/A
- FBIO N/A
- Fundamental
- Price
- FMY $12.05
- FBIO $1.74
- Analyst Decision
- FMY
- FBIO Strong Buy
- Analyst Count
- FMY 0
- FBIO 3
- Target Price
- FMY N/A
- FBIO $21.00
- AVG Volume (30 Days)
- FMY 10.1K
- FBIO 143.4K
- Earning Date
- FMY 01-01-0001
- FBIO 05-19-2025
- Dividend Yield
- FMY 6.98%
- FBIO N/A
- EPS Growth
- FMY N/A
- FBIO N/A
- EPS
- FMY N/A
- FBIO N/A
- Revenue
- FMY N/A
- FBIO $57,675,000.00
- Revenue This Year
- FMY N/A
- FBIO $63.20
- Revenue Next Year
- FMY N/A
- FBIO $66.70
- P/E Ratio
- FMY N/A
- FBIO N/A
- Revenue Growth
- FMY N/A
- FBIO N/A
- 52 Week Low
- FMY $10.71
- FBIO $1.33
- 52 Week High
- FMY $12.17
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- FMY 50.15
- FBIO 56.74
- Support Level
- FMY $12.00
- FBIO $1.67
- Resistance Level
- FMY $12.11
- FBIO $1.84
- Average True Range (ATR)
- FMY 0.12
- FBIO 0.10
- MACD
- FMY 0.00
- FBIO 0.00
- Stochastic Oscillator
- FMY 47.25
- FBIO 53.85
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.